Furthermore, the design presents a promising approach for leveraging bioactive linear peptides
The peptide shows particular promise for inflammatory bowel conditions
Mandal S, Mukherjee S, Chowdhury KD, Sarkar A, Basu K, Paul S, et al
All NMOSD are classified (according to the leading pathophysiological mechanisms) into diseases with identifiable antibodies against aquaporin 4 AQP4-IgG (NMOSD-AQP4), NMOSD without AQP4-IgG or with unknown AQP4-IgG status and NMOSD with identified antibodies against Myelin Oligodendrocyte Glycoprotein, (NMOSD-MOG)
A large number of chronic health conditions and diseases have been linked to depleted glutathione levels, and numerous studies have demonstrated that replenishing glutathione improves these conditions